Valion Bio, Inc. (VBIO) Total liabilities 2021–2024
Valion Bio, Inc. (VBIO) total liabilities at each fiscal year-end, per SEC filings.
$272,000FY2024 · since FY2021: $1.8M → $272,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | $272,000 | -82.8% |
| FY2023 | $1.6M | -29.8% |
| FY2022 | $2.2M | +27.3% |
| FY2021 | $1.8M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More VBIO financial trends
VBIO RevenueVBIO Net incomeVBIO Net marginVBIO Gross profitVBIO Gross marginVBIO Operating incomeVBIO Operating marginVBIO Operating cash flowVBIO Free cash flowVBIO Capital expendituresVBIO Return on equityVBIO Stock buybacksVBIO Dividends paidVBIO Total assetsVBIO Shareholders’ equityVBIO overview →